To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for certain drugs.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for certain drugs., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Technology.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HBFDA60D8AD634273A04CD8921497F8C5: 1. Short title This Act may be cited as the No Handouts for Drug Advertisements Act.
- Section H81340EE7F5C649BC86BBDCAD1F74915F: 2. Disallowance of deduction for advertising and promotional expenses for certain drugs Part IX of subchapter B of chapter 1 of subtitle A of the Internal...
- Section H2E60A0DF36A94F81B42365DEC296D895: 280I. Disallowance of deduction for direct-to-consumer advertising of certain drugs No deduction shall be allowed under this chapter for expenses relating to...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for certain drugs., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture, Technology
Primary Purpose
This bill, To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for certain drugs., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMr. Murphy (for himself, Ms. Craig, Mr. Begich, and Ms. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology